Selected research
Industry Research
Stentless Bioprostheses Industry Research Report 2026
Market perspective
The global Stentless Bioprostheses market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Stentless Bioprostheses is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Stentless Bioprostheses is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Stentless Bioprostheses is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Stentless Bioprostheses include Abbott, Medtronic, Pulmonx Corporation, Meril Life Sciences Pvt. Ltd, LivaNova PLC, LeMaitre Vascular, Inc, Edwards Lifesciences Corporation, CryoLife, Inc and Colibri Heart Valve, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Stentless Bioprostheses market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stentless Bioprostheses Market by Company
Abbott
Medtronic
Pulmonx Corporation
Meril Life Sciences Pvt. Ltd
LivaNova PLC
LeMaitre Vascular, Inc
Edwards Lifesciences Corporation
CryoLife, Inc
Colibri Heart Valve
Braile Biomedica
Stentless Bioprostheses Segment by Type
Allograft
Xenograft
Autograft
Stentless Bioprostheses Segment by Application
Clinics
Hospitals
Ambulatory Surgical Centers
Stentless Bioprostheses Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stentless Bioprostheses market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stentless Bioprostheses and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stentless Bioprostheses.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Stentless Bioprostheses manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Stentless Bioprostheses by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Stentless Bioprostheses in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Allograft
- Xenograft
- Autograft
Applications
- Clinics
- Hospitals
- Ambulatory Surgical Centers
Companies covered
- Abbott
- Medtronic
- Pulmonx Corporation
- Meril Life Sciences Pvt. Ltd
- LivaNova PLC
- LeMaitre Vascular, Inc
- Edwards Lifesciences Corporation
- CryoLife, Inc
- Colibri Heart Valve
- Braile Biomedica
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Stentless Bioprostheses Market Size (2021-2032)
- 2.2.2 Global Stentless Bioprostheses Sales (2021-2032)
- 2.2.3 Global Stentless Bioprostheses Market Average Price (2021-2032)
- 2.3 Stentless Bioprostheses by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Allograft
- 2.3.3 Xenograft
- 2.3.4 Autograft
- 2.4 Stentless Bioprostheses by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Ambulatory Surgical Centers
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Stentless Bioprostheses Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Stentless Bioprostheses Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Stentless Bioprostheses Revenue of Manufacturers (2021-2026)
- 3.4 Global Stentless Bioprostheses Average Price by Manufacturers (2021-2026)
- 3.5 Global Stentless Bioprostheses Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Stentless Bioprostheses, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Stentless Bioprostheses, Product Type & Application
- 3.8 Global Manufacturers of Stentless Bioprostheses, Established Date
- 3.9 Global Stentless Bioprostheses Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Stentless Bioprostheses Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Medtronic
- 4.2.1 Medtronic Company Information
- 4.2.2 Medtronic Business Overview
- 4.2.3 Medtronic Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medtronic Stentless Bioprostheses Product Portfolio
- 4.2.5 Medtronic Recent Developments
- 4.3 Pulmonx Corporation
- 4.3.1 Pulmonx Corporation Company Information
- 4.3.2 Pulmonx Corporation Business Overview
- 4.3.3 Pulmonx Corporation Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pulmonx Corporation Stentless Bioprostheses Product Portfolio
- 4.3.5 Pulmonx Corporation Recent Developments
- 4.4 Meril Life Sciences Pvt. Ltd
- 4.4.1 Meril Life Sciences Pvt. Ltd Company Information
- 4.4.2 Meril Life Sciences Pvt. Ltd Business Overview
- 4.4.3 Meril Life Sciences Pvt. Ltd Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Meril Life Sciences Pvt. Ltd Stentless Bioprostheses Product Portfolio
- 4.4.5 Meril Life Sciences Pvt. Ltd Recent Developments
- 4.5 LivaNova PLC
- 4.5.1 LivaNova PLC Company Information
- 4.5.2 LivaNova PLC Business Overview
- 4.5.3 LivaNova PLC Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LivaNova PLC Stentless Bioprostheses Product Portfolio
- 4.5.5 LivaNova PLC Recent Developments
- 4.6 LeMaitre Vascular, Inc
- 4.6.1 LeMaitre Vascular, Inc Company Information
- 4.6.2 LeMaitre Vascular, Inc Business Overview
- 4.6.3 LeMaitre Vascular, Inc Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LeMaitre Vascular, Inc Stentless Bioprostheses Product Portfolio
- 4.6.5 LeMaitre Vascular, Inc Recent Developments
- 4.7 Edwards Lifesciences Corporation
- 4.7.1 Edwards Lifesciences Corporation Company Information
- 4.7.2 Edwards Lifesciences Corporation Business Overview
- 4.7.3 Edwards Lifesciences Corporation Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Edwards Lifesciences Corporation Stentless Bioprostheses Product Portfolio
- 4.7.5 Edwards Lifesciences Corporation Recent Developments
- 4.8 CryoLife, Inc
- 4.8.1 CryoLife, Inc Company Information
- 4.8.2 CryoLife, Inc Business Overview
- 4.8.3 CryoLife, Inc Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CryoLife, Inc Stentless Bioprostheses Product Portfolio
- 4.8.5 CryoLife, Inc Recent Developments
- 4.9 Colibri Heart Valve
- 4.9.1 Colibri Heart Valve Company Information
- 4.9.2 Colibri Heart Valve Business Overview
- 4.9.3 Colibri Heart Valve Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Colibri Heart Valve Stentless Bioprostheses Product Portfolio
- 4.9.5 Colibri Heart Valve Recent Developments
- 4.10 Braile Biomedica
- 4.10.1 Braile Biomedica Company Information
- 4.10.2 Braile Biomedica Business Overview
- 4.10.3 Braile Biomedica Stentless Bioprostheses Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Braile Biomedica Stentless Bioprostheses Product Portfolio
- 4.10.5 Braile Biomedica Recent Developments
5 Global Stentless Bioprostheses Market Scenario by Region
- 5.1 Global Stentless Bioprostheses Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Stentless Bioprostheses Sales by Region: 2021-2032
- 5.2.1 Global Stentless Bioprostheses Sales by Region: 2021-2026
- 5.2.2 Global Stentless Bioprostheses Sales by Region: 2027-2032
- 5.3 Global Stentless Bioprostheses Revenue by Region: 2021-2032
- 5.3.1 Global Stentless Bioprostheses Revenue by Region: 2021-2026
- 5.3.2 Global Stentless Bioprostheses Revenue by Region: 2027-2032
- 5.4 North America Stentless Bioprostheses Market Facts & Figures by Country
- 5.4.1 North America Stentless Bioprostheses Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Stentless Bioprostheses Sales by Country (2021-2032)
- 5.4.3 North America Stentless Bioprostheses Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Stentless Bioprostheses Market Facts & Figures by Country
- 5.5.1 Europe Stentless Bioprostheses Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Stentless Bioprostheses Sales by Country (2021-2032)
- 5.5.3 Europe Stentless Bioprostheses Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Stentless Bioprostheses Market Facts & Figures by Country
- 5.6.1 Asia Pacific Stentless Bioprostheses Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Stentless Bioprostheses Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Stentless Bioprostheses Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Stentless Bioprostheses Market Facts & Figures by Country
- 5.7.1 South America Stentless Bioprostheses Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Stentless Bioprostheses Sales by Country (2021-2032)
- 5.7.3 South America Stentless Bioprostheses Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Stentless Bioprostheses Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Stentless Bioprostheses Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Stentless Bioprostheses Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Stentless Bioprostheses Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Stentless Bioprostheses Sales by Type (2021-2032)
- 6.1.1 Global Stentless Bioprostheses Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Stentless Bioprostheses Sales Market Share by Type (2021-2032)
- 6.2 Global Stentless Bioprostheses Revenue by Type (2021-2032)
- 6.2.1 Global Stentless Bioprostheses Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Stentless Bioprostheses Revenue Market Share by Type (2021-2032)
- 6.3 Global Stentless Bioprostheses Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Stentless Bioprostheses Sales by Application (2021-2032)
- 7.1.1 Global Stentless Bioprostheses Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Stentless Bioprostheses Sales Market Share by Application (2021-2032)
- 7.2 Global Stentless Bioprostheses Revenue by Application (2021-2032)
- 7.2.1 Global Stentless Bioprostheses Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Stentless Bioprostheses Revenue Market Share by Application (2021-2032)
- 7.3 Global Stentless Bioprostheses Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Stentless Bioprostheses Value Chain Analysis
- 8.1.1 Stentless Bioprostheses Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Stentless Bioprostheses Production Mode & Process
- 8.2 Stentless Bioprostheses Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Stentless Bioprostheses Distributors
- 8.2.3 Stentless Bioprostheses Customers
9 Global Stentless Bioprostheses Analyzing Market Dynamics
- 9.1 Stentless Bioprostheses Industry Trends
- 9.2 Stentless Bioprostheses Industry Drivers
- 9.3 Stentless Bioprostheses Industry Opportunities and Challenges
- 9.4 Stentless Bioprostheses Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst